IV ALD403: Phase IIb data

Top-line data from a double-blind, international Phase IIb trial in 588 patients with chronic migraine showed that single doses of 100 and 300 mg

Read the full 241 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE